retatrutide approved Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide Side Effects Research |
Description
While the first drug in this class, exenatide (Byetta), was approved by the FDA in 2005, more recent drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) outperform the older drugs in the class and other anti-obesity medications

You may also like: Comprehensive Weight Loss Treatment Comparison (Read This First!)

Concurrent medications and medical conditions: Patients taking GLP-1 medications often have multiple comorbidities and take other medications that may affect respiratory function

J Clin Invest 110:4352, 2002 [ Links ] 40

Chronic kidney disease: assessment and management (NG203) Recommendations

Want to go deeper on GLP-1 medications and heart health